The present study also points to the modification of inflammatory markers in COVID-19/PCI, as well as to the high values of the average concentrations for serum CRP and LDH in patients with chronic respiratory diseases, especially asthma and COPD (Figure 5, Table S1 Supplementary Materials). This evidence concerns the gene CRP and chronic obstructive pulmonary disease.